Arix Bioscience PLC: Director/PDMR Shareholdings
Arix Bioscience PLC
Arix Bioscience PLC: Director/PDMR Shareholdings
17-Dec-2021 / 11:12 GMT/BST
Arix Bioscience plc
Director/PDMR Shareholdings
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Robert Lyne
2
Reason for the notification
a)
Position/status
CEO and General Counsel
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arix Bioscience plc
b)
LEI
213800OVT3AHQCXNIX43
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code
GB00BD045071
b)
Nature of the transaction
Share purchase
c)
Price(s) and volume(s)
Price(s)
Volume(s)
120.00p
41,666.00
d)
Aggregated information
- Aggregated volume
N/A single transaction
- Price
£49,999.20
e)
Date of the transaction
16 December 2021
f)
Place of the transaction
London Stock Exchange
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Peregrine Moncreiffe
2
Reason for the notification
a)
Position/status
Non-Executive Director and Chair of the Board
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arix Bioscience plc
b)
LEI
213800OVT3AHQCXNIX43
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code
GB00BD045071
b)
Nature of the transaction
Share purchase
c)
Price(s) and volume(s)
Price(s)
Volume(s)
119.00p
84,000.00
d)
Aggregated information
- Aggregated volume
N/A single transaction
- Price
£99,959.98
e)
Date of the transaction
16 December 2021
f)
Place of the transaction
London Stock Exchange
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Sir Michael Bunbury
2
Reason for the notification
a)
Position/status
Non-Executive Director and Senior Independent Director (SID)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arix Bioscience plc
b)
LEI
213800OVT3AHQCXNIX43
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code
GB00BD045071
b)
Nature of the transaction
Share purchase
c)
Price(s) and volume(s)
Price(s)
Volume(s)
119.00p
40,000.00
d)
Aggregated information
- Aggregated volume
N/A single transaction
- Price
£47,600.00
e)
Date of the transaction
16 December 2021
f)
Place of the transaction
London Stock Exchange
For further information please contact:
Derringtons Limited, Company Secretary
+44 20 8819 6486
Ends.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
1259488 17-Dec-2021